🔎 Trials Near Me

Akèy › Kasinom Selil Transizyonèl (Urotelyal) › Pennsylvania › Pittsburgh

Etid klinik pou Kasinom Selil Transizyonèl (Urotelyal) nan Pittsburgh, PA

5 etid pou Kasinom Selil Transizyonèl (Urotelyal) ap chèche patisipan nan sit nan ak bò kote Pittsburgh (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.

Tèks ofisyèl etid la (Anglè)

Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →

A Study Comparing the Combination of Pembrolizumab and Sacituzumab Govitecan-hziy Versus Standard of Care in the Treatment of Advanced Urothelial Cancer

Ap rekriteFaz 3
  • Allegheny General Hospital, Pittsburgh
  • UPMC-Saint Margaret, Pittsburgh
  • West Penn Hospital, Pittsburgh
  • ak 9 plis
Laj 18 ak plis · Tout sèks · Mizajou Oct 5, 2026 · NCT06524544

Study of Zanzalintinib in Combination With Immuno-Oncology or Other Agents in Participants With Solid Tumors

Ap rekriteFaz 1
  • Exelixis Clinical Site #32, Pittsburgh
Laj 18 ak plis · Tout sèks · Mizajou Oct 1, 2026 · NCT05176483

Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors

Ap rekriteFaz 2
  • UPMC Hillman Cancer Center, Pittsburgh
  • UPMC-Passavant Hospital, Pittsburgh
  • UPMC-Saint Clair Hospital Cancer Center, Pittsburgh
  • ak 2 plis
Laj 18 ak plis · Tout sèks · Mizajou Sep 30, 2026 · NCT03866382

A Substudy of Investigational Agents in Programmed Cell Death-1/Ligand 1 (PD-1/L1) Refractory Locally Advanced or Metastatic Urothelial Carcinoma (mUC) (MK-3475-04A)

Ap rekriteFaz 1/2
  • UPMC Hillman Cancer Center ( Site 1014), Pittsburgh
Laj 18 ak plis · Tout sèks · Mizajou Sep 28, 2026 · NCT05562830

A Study of Vepugratinib (LY3866288) in Participants With Cancer in the Urinary Tract

Ap rekriteFaz 3
  • AHN Allegheny General Hospital, Pittsburgh
Laj 18 ak plis · Tout sèks · Mizajou Sep 22, 2026 · NCT07218380

Etid Kasinom Selil Transizyonèl (Urotelyal) nan lòt vil

Lòt etid nan Pittsburgh

Sous ClinicalTrials.gov, done yo ranmase Oct 6, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.